CRELUX GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:CRELUX GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013939
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Crelux GmbH (Crelux), a subsidiary of WuXi AppTec Co Ltd is a drug discovery solution provider that discovers drug solutions for pharmacy, biotech and research organizations. The company services include customized and integrated solutions in drug discovery, X-ray crystallography, protein supply, biophysical analysis and screening. It develops fragment screening platform which include measurements of enzymatic activities, Kon/off binding kinetics, KD analyses and stability determination of proteins. Crelux’s X intract biophysical analytics and screening platform is made of a versatile series of orthogonal assay technologies for hit validation. The company’s robotics-enhanced screening platform provides efficient, cutting-edge technologies for protein biophysical services and for the analysis and validation of compounds. Crelux is headquartered in Martinsried, Germany.

CRELUX GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CRELUX GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CRELUX GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AiCuris Enters Into Drug Discovery Agreement With 4SC Discovery And Crelux 10
UCB Enters Into Drug Discovery Agreement With Crelux And 4SC Discovery 12
4SC Enters Into Co-Development Agreement With Crelux And Ribological 13
Acquisition 14
WuXi AppTec Acquires Crelux 14
CRELUX GmbH – Key Competitors 15
CRELUX GmbH – Key Employees 16
CRELUX GmbH – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
CRELUX GmbH, Pharmaceuticals & Healthcare, Key Facts 2
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CRELUX GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CRELUX GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AiCuris Enters Into Drug Discovery Agreement With 4SC Discovery And Crelux 10
UCB Enters Into Drug Discovery Agreement With Crelux And 4SC Discovery 12
4SC Enters Into Co-Development Agreement With Crelux And Ribological 13
WuXi AppTec Acquires Crelux 14
CRELUX GmbH, Key Competitors 15
CRELUX GmbH, Key Employees 16

★海外企業調査レポート[CRELUX GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Specialist Investment Properties PLC:企業の戦略・SWOT・財務分析
    Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report Summary Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Ferring International Center SA:企業の戦略的SWOT分析
    Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Wuxi Pharmatech (Cayman) Inc:企業のM&A・事業提携・投資動向
    Wuxi Pharmatech (Cayman) Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wuxi Pharmatech (Cayman) Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Arla Foods Ingredients Group P/S:企業の戦略・SWOT・財務情報
    Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report Summary Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Hong Kong Aircraft Engineering Co. Ltd:企業の戦略的SWOT分析
    Hong Kong Aircraft Engineering Co. Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • China Shineway Pharmaceutical Group Ltd (2877):企業の財務・戦略的SWOT分析
    Summary China Shineway Pharmaceutical Group Ltd (China Shineway) is a pharmaceutical company that offers development, manufacture and sales of Chinese medicines. The company’s products comprise shenmai injection, qingkailing injection, huangqi injection, shuxiening injection, wufu xinnaoqing soft ca …
  • MetaStat Inc (MTST):医療機器:M&Aディール及び事業提携情報
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • AgaMatrix Inc:医療機器:M&Aディール及び事業提携情報
    Summary AgaMatrix Inc (AgaMatrix) is a medical device company that offers biosensors and blood glucose monitors. The company designs, develops and manufactures diabetes products for pharmaceutical companies. Its products comprise Jazz Wireless 2, blood glucose monitors, Connected Health and AgaMatri …
  • Burmeister & Wain Scandinavian Contractor AS:企業の戦略的SWOT分析
    Burmeister & Wain Scandinavian Contractor AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Northfork Electric Cooperative, Inc.:発電所・企業SWOT分析
    Northfork Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • VOCO GmbH:企業の戦略的SWOT分析
    VOCO GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • BMG Resources Ltd (BMG):企業の財務・戦略的SWOT分析
    Summary BMG Resources Ltd (BMG), formerly known as Brazilian Metals Group Ltd, is a mineral exploration company that explores lithium brine in Chile. The company's portfolio includes exploration tenements located in the Republic of Cyprus. Its product portfolio include nickel, gold, copper, cobalt, …
  • CSR Ltd:企業の戦略・SWOT・財務情報
    CSR Ltd - Strategy, SWOT and Corporate Finance Report Summary CSR Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Engro Corp Ltd (ENGRO):企業の財務・戦略的SWOT分析
    Engro Corp Ltd (ENGRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cadogan Petroleum Plc (CAD):石油・ガス:M&Aディール及び事業提携情報
    Summary Cadogan Petroleum Plc (Cadogan) is an independent upstream energy company that carries out exploration, development and production of oil and gas. It also conducts gas trading operations, which include the import of gas from European countries, and purchase and sale in the domestic market. T …
  • Reliance Worldwide Corporation Ltd (RWC):企業の財務・戦略的SWOT分析
    Reliance Worldwide Corporation Ltd (RWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Sanofi (SAN):企業の財務・戦略的SWOT分析
    Sanofi (SAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Genesee & Wyoming Inc.:企業のM&A・事業提携・投資動向
    Genesee & Wyoming Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genesee & Wyoming Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Ferrellgas Partners LP (FGP):石油・ガス:M&Aディール及び事業提携情報
    Summary Ferrellgas Partners LP (Ferrellgas) is an oil and gas company that supplies propane and related equipment. The company provides transportation, wholesale marketing, and distribution of propane. It also carries out selling refined fuels and feedstocks. Ferrellgas provides propane crop drying, …
  • Sampo plc:企業のM&A・事業提携・投資動向
    Sampo plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sampo plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆